EUDA Ebitda from 2010 to 2024

EUDAW Stock   0.09  0.01  5.26%   
EUDA Health EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA will likely drop to about -8.7 M in 2024. During the period from 2010 to 2024, EUDA Health EBITDA regression line of quarterly data had r-squared of  0.30 and coefficient of variation of (297.51). View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-8.3 M
Current Value
-8.7 M
Quarterly Volatility
6.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EUDA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EUDA Health's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 183.4 K or Interest Expense of 22.1 K, as well as many indicators such as Price To Sales Ratio of 11.37, Dividend Yield of 0.0 or Days Sales Outstanding of 22.38. EUDA financial statements analysis is a perfect complement when working with EUDA Health Valuation or Volatility modules.
  
Check out the analysis of EUDA Health Correlation against competitors.

Latest EUDA Health's Ebitda Growth Pattern

Below is the plot of the Ebitda of EUDA Health Holdings over the last few years. It is EUDA Health's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EUDA Health's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

EUDA Ebitda Regression Statistics

Arithmetic Mean(2,326,987)
Coefficient Of Variation(297.51)
Mean Deviation4,612,035
Median484,241
Standard Deviation6,922,928
Sample Variance47.9T
Range25.9M
R-Value(0.55)
Mean Square Error35.9T
R-Squared0.30
Significance0.03
Slope(853,148)
Total Sum of Squares671T

EUDA Ebitda History

2024-8.7 M
2023-8.3 M
2022-24.6 M
20211.3 M

About EUDA Health Financial Statements

EUDA Health investors use historical fundamental indicators, such as EUDA Health's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in EUDA Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA-8.3 M-8.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for EUDA Stock Analysis

When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.